ABEO
Abeona Therapeutics Inc
5.40$
-1.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | -100.0% | – | +60.9% | +30.5% | – | |
| – | +2,303.3% | +0.4% | +130.2% | -56.7% | +7.5% | +5.0% | -87.7% | +388.0% | +481.4% | +25.7% | +17.2% | – | |
| – | – | – | – | – | – | – | – | -262.7% | – | +99.6% | +39.7% | – | |
| – | +3.2% | -2.3% | +27.9% | -3.0% | +0.6% | +10.5% | -40.2% | -29.1% | +59.2% | +42.4% | -47.5% | – | |
| – | +40.3% | +22.2% | +21.4% | -25.9% | +19.9% | +27.5% | +75.2% | +12.6% | -2.8% | +3.8% | -18.8% | – | |
| – | +10.5% | +14.8% | +24.7% | -14.1% | +3.6% | +24.1% | +17.1% | +1.9% | +8.3% | +10.6% | -26.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.8% | +773.4% | +12.6% | +2.8% | -1.8% | -7.8% | -4.1% | -5.9% | -1.9% | -6.1% | -16.1% | – | |
| – | – | – | – | -508.7% | – | – | – | -116.4% | – | – | – | – | |
| – | -14.3% | +0.5% | -344.9% | – | – | – | – | -198.0% | – | – | – | – | |
| – | – | – | – | -508.7% | – | – | – | -104.7% | – | – | – | – | |
| – | – | – | – | -410.4% | – | – | – | -114.7% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.